Baudax Bio Q2 EPS $(1.05) Up From $(7.18) YoY

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(1.05) per share. This is a 85.38 percent increase over losses of $(7.18) per share from the same period last year.

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(1.05) per share. This is a 85.38 percent increase over losses of $(7.18) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information And Announces Its Net Asset Value And Asset Coverage Ratios At September 30, 2023; Fund’s Net Assets Were $389.9M And Its Net Asset Value Was $8.26/Share

As of September 30, 2023, the Fund's net assets were $389.9 million and its net asset value per share was $8.26. As of September 30, 2023, the Fund's asset coverage ratio under the 1940 Act with

KMF